Responses to the COVID-19 pandemic

UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility

Retrieved on: 
Wednesday, June 2, 2021
Infectious diseases, Biotechnology, Pharmaceutical, Health, COVID-19, COVID-19 vaccines, Clinical trials, Medicine, Responses to the COVID-19 pandemic, Medical research, RNA vaccines, Moderna COVID-19 vaccine, COVID-19 vaccine, COVAX, Moderna, RNA vaccine, the COVID-19 Vaccine Moderna, Moderna, THE COVID-19 VACCINE MODERNA, MODERNA

We are proud and humbled to be able to supply our vaccine through this long-term agreement with UNICEF in support of efforts to end this pandemic, said Stphane Bancel, Chief Executive Officer of Moderna.

Key Points: 
  • We are proud and humbled to be able to supply our vaccine through this long-term agreement with UNICEF in support of efforts to end this pandemic, said Stphane Bancel, Chief Executive Officer of Moderna.
  • We share in the mission of the COVAX Facility to ensure global access to vaccines including in low- and middle-income countries around the world.
  • The COVID-19 Vaccine Moderna (referred to in the U.S. as the Moderna COVID-19 Vaccine) is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center.
  • On May 12, the U.S Food and Drug Administration granted the Moderna COVID-19 Vaccine Fast Track designation.

Moderna Provides Storage Update & Announces the U.S. FDA Authorizes Up To 15-Doses Per Vial of its COVID-19 Vaccine

Retrieved on: 
Friday, April 2, 2021
FDA, Health, Infectious diseases, Clinical trials, Pharmaceutical, Biotechnology, COVID-19, COVID-19 vaccines, Clinical trials, Medicine, Responses to the COVID-19 pandemic, Medical research, RNA vaccines, Moderna COVID-19 vaccine, Adenoviridae, COVID-19 vaccine, Vaccine, Pfizer–BioNTech COVID-19 vaccine

The FDA also authorized inclusion of a new vial presentation with a maximum of 15 doses of its COVID-19 vaccine.

Key Points: 
  • The FDA also authorized inclusion of a new vial presentation with a maximum of 15 doses of its COVID-19 vaccine.
  • The Moderna COVID-19 Vaccine now can be supplied in two vial presentations (a multiple-dose vial containing a maximum of 11 doses or a multiple-dose vial containing a maximum of 15 doses).
  • Thank you to the U.S. FDA and CDC for their ongoing collaboration, said Stphane Bancel, Chief Executive Officer of Moderna.
  • Individuals who have received one dose of Moderna COVID-19 Vaccine should receive a second dose of Moderna COVID-19 Vaccine to complete the vaccination series.

Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Pediatric Population

Retrieved on: 
Tuesday, March 16, 2021
Health, Consumer, Infectious diseases, Children, Clinical trials, Pharmaceutical, Biotechnology, COVID-19 vaccines, Clinical trials, COVID-19, Medicine, Responses to the COVID-19 pandemic, Moderna COVID-19 vaccine, COVID-19 vaccine, Vaccine, COVID-19 vaccination in Italy, Oxford–AstraZeneca COVID-19 vaccine, the Moderna COVID-19 Vaccine, Moderna

It is humbling to know that 17.8 million adults in the U.S. have received the Moderna COVID-19 Vaccine to date.

Key Points: 
  • It is humbling to know that 17.8 million adults in the U.S. have received the Moderna COVID-19 Vaccine to date.
  • The first participant in the NIAID-led Phase 1 study of the Moderna COVID-19 Vaccine was dosed on March 16, 2020, 63 days from sequence selection to Phase 1 study dosing.
  • On November 30, 2020, Moderna announced the primary efficacy analysis of the Phase 3 study of the vaccine conducted on 196 cases.
  • Individuals who have received one dose of Moderna COVID-19 Vaccine should receive a second dose of Moderna COVID-19 Vaccine to complete the vaccination series.

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

Retrieved on: 
Saturday, March 6, 2021
Health, FDA, Infectious diseases, Clinical trials, Pharmaceutical, Biotechnology, COVID-19, COVID-19 vaccines, Medical research, Medicine, Responses to the COVID-19 pandemic, Clinical trials, RNA vaccines, Moderna COVID-19 vaccine, Moderna, COVID-19 vaccine, RNA vaccine, Vaccine, the COVID-19 Vaccine Moderna, Moderna

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the Government of The Philippines for 13 million doses of the COVID-19 Vaccine Moderna.

Key Points: 
  • Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the Government of The Philippines for 13 million doses of the COVID-19 Vaccine Moderna.
  • A separate agreement with the Philippine Government and private sector for the supply of an additional 7 million doses is also anticipated.
  • We thank the Government and the private sector for their collaboration to bring the COVID-19 Vaccine Moderna to the Philippines, said Stphane Bancel, Chief Executive Officer of Moderna.
  • The COVID-19 Vaccine Moderna (referred to in the U.S. as the Moderna COVID-19 Vaccine) is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from NIAIDs Vaccine Research Center.

Canada Purchases Additional 4 Million Doses of Moderna’s COVID-19 Vaccine

Retrieved on: 
Friday, February 12, 2021
Research, General Health, Pharmaceutical, Infectious diseases, Hospitals, Genetics, Clinical trials, Science, Biotechnology, Medical Supplies, FDA, Health, Responses to the COVID-19 pandemic, Medical research, Medicine, RNA vaccines, Health sciences, Clinical trials, Moderna COVID-19 vaccine, Moderna, COVID-19 vaccine, Vaccine, Pfizer–BioNTech COVID-19 vaccine, COVID-19 vaccination campaign in Italy

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Canadian Government has increased its confirmed order commitment by 4 million doses of the COVID-19 Vaccine Moderna bringing its confirmed order commitment to 44 million doses.

Key Points: 
  • Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Canadian Government has increased its confirmed order commitment by 4 million doses of the COVID-19 Vaccine Moderna bringing its confirmed order commitment to 44 million doses.
  • We appreciate our collaboration with the Canadian government as we seek to defeat the pandemic with our vaccine.
  • Todays increased supply agreement from the Canadian government reaffirms the confidence in Modernas COVID-19 vaccine, said Stephane Bancel, Chief Executive Officer of Moderna.
  • On December 23, Health Canada authorized the COVID-19 Vaccine Moderna for the immunization of people 18 years of age and older under an Interim Order.

Moderna Announces COVID-19 Vaccine Supply Agreements with the Government of Taiwan for 5 Million Doses and the Government of Colombia for 10 Million Doses

Retrieved on: 
Tuesday, February 9, 2021
Research, General Health, Pharmaceutical, Infectious diseases, Hospitals, Genetics, Clinical trials, Science, Biotechnology, Medical Supplies, FDA, Health, RNA vaccines, Medical research, Responses to the COVID-19 pandemic, Medicine, Health sciences, Clinical trials, Moderna COVID-19 vaccine, Moderna, COVID-19 vaccine, BioNTech, Vaccine, BioNTech, the Moderna COVID-19 Vaccine, Moderna

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two supply agreements for the COVID-19 Vaccine Moderna: one with the government of Taiwan for 5 million doses and another with the government of Colombia for 10 million doses.

Key Points: 
  • Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two supply agreements for the COVID-19 Vaccine Moderna: one with the government of Taiwan for 5 million doses and another with the government of Colombia for 10 million doses.
  • The COVID-19 Vaccine Moderna is not currently approved for use in Taiwan or Colombia, and the Company will work with regulators to pursue necessary approvals prior to distribution.
  • We thank the governments of both Taiwan and Colombia for partnering with us to bring the COVID-19 Vaccine Moderna to Taiwan and Colombia.
  • On May 12, the U.S Food and Drug Administration granted the Moderna COVID-19 Vaccine Fast Track designation.

United Kingdom Medicines and Healthcare products Regulatory Agency Authorizes Use of COVID-19 Vaccine Moderna

Retrieved on: 
Friday, January 8, 2021
Infectious diseases, Biotechnology, Pharmaceutical, Health, Responses to the COVID-19 pandemic, Medicine, Health sciences, Medical research, Clinical trials, COVID-19 vaccine, RNA vaccine, Moderna, Medicines and Healthcare products Regulatory Agency, Vaccine, Coronavirus disease, Tozinameran, the COVID-19 Vaccine Moderna, Moderna

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the UKs Medicines and Healthcare products Regulatory Agency (MHRA) has approved its mRNA vaccine against COVID-19 (COVID-19 Vaccine Moderna) for use under Regulation 174.

Key Points: 
  • Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the UKs Medicines and Healthcare products Regulatory Agency (MHRA) has approved its mRNA vaccine against COVID-19 (COVID-19 Vaccine Moderna) for use under Regulation 174.
  • The United Kingdom government has also exercised its option to purchase an additional 10 million doses of the COVID-19 Vaccine Moderna, bringing its confirmed order commitment to 17 million doses.
  • The first deliveries of the COVID-19 Vaccine Moderna to the UK from Modernas dedicated non-U.S. supply chain are expected to commence early in 2021.
  • The COVID-19 Vaccine Moderna has been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA), based upon the recommendation of the Commission on Human Medicines, which authorizes the COVID-19 Vaccine Moderna for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus in individuals 18 years of age and older.

Canada's COVID-19 exposure notification app now available in the Northwest Territories

Retrieved on: 
Thursday, November 26, 2020
Mobile applications, Application software, Software, COVID Alert, COVID-19 pandemic in Canada, Responses to the COVID-19 pandemic, Exposure Notification, Justin Trudeau, Shopify, COVID-19 apps

The Prime Minister, Justin Trudeau, and the Premier of the Northwest Territories, Caroline Cochrane, today announced that people in the Northwest Territories can now receive one-time keys from their health authority to use with COVID Alert, Canada's COVID-19 exposure notification app.

Key Points: 
  • The Prime Minister, Justin Trudeau, and the Premier of the Northwest Territories, Caroline Cochrane, today announced that people in the Northwest Territories can now receive one-time keys from their health authority to use with COVID Alert, Canada's COVID-19 exposure notification app.
  • This is exactly what we are doing and we are pleased to make the COVID-19 Alert app available in the Northwest Territories.
  • Users who already have the app downloaded should keep both the app and their device's operating system up to date.
  • It builds upon an exposure notification solution developed by Shopify volunteers in coordination with the non-profit Linux Foundation Public Health .

Canada's COVID-19 exposure notification app now available in Quebec

Retrieved on: 
Monday, October 5, 2020
Mobile applications, Application software, Software, Responses to the COVID-19 pandemic, Apple Inc., Exposure Notification, Google, COVID Alert, Shopify, COVID-19 apps, Covid Watch

The Government of Canada and the Government of Quebec confirmed today that people in Quebec can now receive one-time keys from their health authorities to use with COVID Alert, Canada's COVID-19 exposure notification app.

Key Points: 
  • The Government of Canada and the Government of Quebec confirmed today that people in Quebec can now receive one-time keys from their health authorities to use with COVID Alert, Canada's COVID-19 exposure notification app.
  • This is exactly what we are doing and we are pleased to make the COVID-19 Alert app available in Quebec.
  • The Government of Canada established the COVID-19 Exposure Notification App Advisory Council to ensure the app meets the highest standards in public health outcomes, privacy, and technology.
  • It builds upon an exposure notification solution developed by Shopify volunteers in coordination with the non-profit Linux Foundation Public Health .

Canada's COVID-19 exposure notification app soon to be available in Nova Scotia

Retrieved on: 
Friday, October 2, 2020
Application software, Mobile applications, Software, COVID Alert, COVID-19 pandemic in Canada, Responses to the COVID-19 pandemic, Exposure Notification, Stephen McNeil, NOVA SCOTIA, COVID Tracker Ireland, COVID-19 apps

The Prime Minister, Justin Trudeau, and the Premier of Nova Scotia, Stephen McNeil, today announced that people in Nova Scotia will soon be able to receive one-time keys from their health authorities to use with COVID Alert, Canada's COVID-19 exposure notification app.

Key Points: 
  • The Prime Minister, Justin Trudeau, and the Premier of Nova Scotia, Stephen McNeil, today announced that people in Nova Scotia will soon be able to receive one-time keys from their health authorities to use with COVID Alert, Canada's COVID-19 exposure notification app.
  • COVID Alert is available for download to all Canadians, and the application will be fully operational in Nova Scotia and Prince Edward Island in the very near future.
  • This is exactly what we are doing and we are pleased to make the COVID-19 Alert app available in Nova Scotia soon.
  • The Government of Canada established the COVID-19 Exposure Notification App Advisory Council to ensure the app meets the highest standards in public health outcomes, privacy, and technology.